Literature DB >> 33406768

Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Trophoblast Functions.

Lin Peng1, Huixia Yang1, Yao Ye2, Zhi Ma1, Christina Kuhn3, Martina Rahmeh1, Sven Mahner1, Antonis Makrigiannakis4, Udo Jeschke1,5, Viktoria von Schönfeldt3.   

Abstract

Peroxisome proliferator-activated receptors (PPARα, PPARβ/δ, and PPARγ) belong to the transcription factor family, and they are highly expressed in all types of trophoblast during pregnancy. The present review discusses currently published papers that are related to the regulation of PPARs via lipid metabolism, glucose metabolism, and amino acid metabolism to affect trophoblast physiological conditions, including differentiation, maturation, secretion, fusion, proliferation, migration, and invasion. Recent pieces of evidence have proven that the dysfunctions of PPARs in trophoblast lead to several related pregnancy diseases such as recurrent miscarriage, preeclampsia, intrauterine growth restriction, and gestational diabetes mellitus. Moreover, the underlying mechanisms of PPARs in the control of these processes have been discussed as well. Finally, this review's purposes are to provide more knowledge about the role of PPARs in normal and disturbed pregnancy with trophoblast, so as to find PPAR ligands as a potential therapeutic target in the treatment and prevention of adverse pregnancy outcomes.

Entities:  

Keywords:  cytotrophoblast; extravillous trophoblast; functions; peroxisome proliferator-activated receptors (PPARs)

Year:  2021        PMID: 33406768     DOI: 10.3390/ijms22010433

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  7 in total

1.  Decreased Fatty Acid Transporter FABP1 and Increased Isoprostanes and Neuroprostanes in the Human Term Placenta: Implications for Inflammation and Birth Weight in Maternal Pre-Gestational Obesity.

Authors:  Livia Belcastro; Carolina S Ferreira; Marcelle A Saraiva; Daniela B Mucci; Antonio Murgia; Carla Lai; Claire Vigor; Camille Oger; Jean-Marie Galano; Gabriela D A Pinto; Julian L Griffin; Alexandre G Torres; Thierry Durand; Graham J Burton; Fátima L C Sardinha; Tatiana El-Bacha
Journal:  Nutrients       Date:  2021-08-12       Impact factor: 5.717

Review 2.  Lipid Metabolism Regulation Based on Nanotechnology for Enhancement of Tumor Immunity.

Authors:  Bin Tu; Yanrong Gao; Feifei Sun; Mingjie Shi; Yongzhuo Huang
Journal:  Front Pharmacol       Date:  2022-03-22       Impact factor: 5.810

3.  Trophectoderm Transcriptome Analysis in LIN28 Knockdown Ovine Conceptuses Suggests Diverse Roles of the LIN28-let-7 Axis in Placental and Fetal Development.

Authors:  Asghar Ali; Muhammad A Iqbal; Muhammad W Abbas; Gerrit J Bouma; Russell V Anthony; Thomas E Spencer; Quinton A Winger
Journal:  Cells       Date:  2022-04-05       Impact factor: 6.600

4.  An Alkaloid from a Highly Invasive Seaweed Increases the Voracity and Reproductive Output of a Model Fish Species.

Authors:  Valentina Schiano; Adele Cutignano; Daniela Maiello; Marianna Carbone; Maria Letizia Ciavatta; Gianluca Polese; Federica Fioretto; Chiara Attanasio; Antonio Palladino; Serena Felline; Antonio Terlizzi; Livia D'Angelo; Paolo de Girolamo; Mimmo Turano; Carla Lucini; Ernesto Mollo
Journal:  Mar Drugs       Date:  2022-08-12       Impact factor: 6.085

Review 5.  Cannabinoids and PPAR Ligands: The Future in Treatment of Polycystic Ovary Syndrome Women with Obesity and Reduced Fertility.

Authors:  Piotr Przybycień; Danuta Gąsior-Perczak; Wojciech Placha
Journal:  Cells       Date:  2022-08-18       Impact factor: 7.666

Review 6.  Birthweight and isolated congenital heart defects - A systematic review and meta-analysis.

Authors:  Moska Aliasi; Maartje C Snoep; Nan van Geloven; Monique C Haak
Journal:  BJOG       Date:  2022-04-15       Impact factor: 7.331

7.  Comprehensive Analysis of Copy Number Variation, Nucleotide Mutation, and Transcription Level of PPAR Pathway-Related Genes in Endometrial Cancer.

Authors:  Minghui Tang; Jingyao Wang; Liangsheng Fan
Journal:  PPAR Res       Date:  2022-01-13       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.